rs1222724752

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_015321.3(CRTC1):​c.334G>A​(p.Gly112Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000958 in 1,460,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000096 ( 0 hom. )

Consequence

CRTC1
NM_015321.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.61

Publications

1 publications found
Variant links:
Genes affected
CRTC1 (HGNC:16062): (CREB regulated transcription coactivator 1) Enables cAMP response element binding protein binding activity. Involved in positive regulation of transcription by RNA polymerase II. Located in cytosol; nuclear body; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12875697).
BS2
High AC in GnomAdExome4 at 14 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRTC1NM_015321.3 linkc.334G>A p.Gly112Ser missense_variant Exon 3 of 14 ENST00000321949.13 NP_056136.2 Q6UUV9-1
CRTC1NM_001098482.2 linkc.382G>A p.Gly128Ser missense_variant Exon 4 of 15 NP_001091952.1 Q6UUV9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRTC1ENST00000321949.13 linkc.334G>A p.Gly112Ser missense_variant Exon 3 of 14 1 NM_015321.3 ENSP00000323332.7 Q6UUV9-1
CRTC1ENST00000338797.10 linkc.382G>A p.Gly128Ser missense_variant Exon 4 of 15 1 ENSP00000345001.5 Q6UUV9-2
CRTC1ENST00000594658.5 linkc.211G>A p.Gly71Ser missense_variant Exon 3 of 14 1 ENSP00000468893.1 M0QX46
CRTC1ENST00000601916.1 linkc.109G>A p.Gly37Ser missense_variant Exon 2 of 10 5 ENSP00000469285.1 M0QXN6

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000404
AC:
1
AN:
247224
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000549
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000958
AC:
14
AN:
1460684
Hom.:
0
Cov.:
32
AF XY:
0.00000963
AC XY:
7
AN XY:
726636
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33474
American (AMR)
AF:
0.00
AC:
0
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26098
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86214
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52692
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000108
AC:
12
AN:
1111722
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
EpiCase
AF:
0.00
EpiControl
AF:
0.0000594

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 28, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.382G>A (p.G128S) alteration is located in exon 4 (coding exon 4) of the CRTC1 gene. This alteration results from a G to A substitution at nucleotide position 382, causing the glycine (G) at amino acid position 128 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
23
DANN
Benign
0.92
DEOGEN2
Benign
0.22
T;.;.;.
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.11
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.85
T;T;D;T
M_CAP
Benign
0.0063
T
MetaRNN
Benign
0.13
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L;.;.;.
PhyloP100
3.6
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.85
N;N;.;.
REVEL
Benign
0.044
Sift
Benign
0.15
T;T;.;.
Sift4G
Benign
0.51
T;T;T;T
Polyphen
0.11
B;B;.;.
Vest4
0.31
MutPred
0.16
Gain of phosphorylation at G112 (P = 0.0134);.;.;.;
MVP
0.33
MPC
0.89
ClinPred
0.35
T
GERP RS
4.0
Varity_R
0.11
gMVP
0.26
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1222724752; hg19: chr19-18856723; COSMIC: COSV58716504; API